Informe Del Mercado 2029 Del Dispositivo De Asistencia Ventricular Izquierda

Mercado global de dispositivos de asistencia ventricular izquierda (LVAD), por tipo de producto (bomba cardíaca, controlador, baterías , cables), terapia ( terapia puente al trasplante (BTT), terapia de destino, terapia puente a la candidatura (BTC), terapia puente a la recuperación (BTR)), grupo de edad (adulto, pediátrico), indicación (insuficiencia cardíaca congestiva, cardiopatía congénita , miocarditis , paro cardíaco, arritmias familiares y arrítmicas, miocardiopatías, insuficiencia cardíaca avanzada, otras), generación (dispositivos de segunda generación, dispositivos de tercera generación, dispositivos de primera generación), durabilidad (largo plazo, plazo intermedio, corto plazo), diseño (axial, centrífugo ), tipo de pulso (no pulsátil, pulsátil), usuario final (hospitales, laboratorios de cateterismo cardíaco, clínicas especializadas, otros), canal de distribución (licitación directa, ventas minoristas, otros), país (EE. UU., Canadá, México, Reino Unido, Alemania, Francia, España, Italia, Países Bajos, Suiza, Rusia, Bélgica, Turquía, Irlanda, Resto de Europa, China, Corea del Sur, Japón, India, Australia, Singapur, Malasia, Indonesia, Tailandia, Filipinas, Resto de Asia-Pacífico, Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos, Egipto, Israel y resto de Medio Oriente y África, Brasil, Argentina y resto de Sudamérica) Tendencias de la industria y pronóstico hasta 2029.

Market Analysis and Insights: Global Left Ventricular Assist Device (LVAD) Market

Se espera que el mercado del dispositivo de asistencia ventricular izquierda (LVAD) aumente el crecimiento del mercado en el período previsto de 2022 a 2029. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR de 9,6% en el período de previsión de 2022 a 2029 y se espera que alcance USD 1,957.56 millones para 2029. El aumento de la población geriátrica junto con el aumento de la prevalencia de enfermedades cardíacas y la presencia de políticas de reembolso favorables entre otros están actuando como conductor del crecimiento del mercado del dispositivo de asistencia ventricular izquierda (LVAD).

El dispositivo de asistencia ventricular izquierda (LVAD) es una bomba que utilizamos para pacientes que han alcanzado la insuficiencia cardíaca en estadio final. El dispositivo de asistencia ventricular izquierda se implanta quirúrgicamente y es una bomba de batería operada, mecánica que ayuda al ventrículo izquierdo a bombear sangre al resto de la sangre. Los LVAD se pueden utilizar como puente a trasplante, terapia de destino, terapia de puente a candidato y terapia de puente a recuperación.

El cambio de estilo de vida activa el desarrollo de enfermedades cardiovasculares que ha mejorado el requisito de los productos del dispositivo de asistencia ventricular izquierda (LVAD) que mejora los resultados de los pacientes y les permite llevar una vida mejor por lo tanto actúa como conductor del mercado del dispositivo de asistencia ventricular izquierda (LVAD). Se espera que las complicaciones y riesgos asociados con la LVAD y el alto costo de la implantación y tratamiento de la LVAD impidan el crecimiento del mercado del dispositivo de asistencia ventricular izquierda (LVAD). Aumentar el gasto sanitario y aumentar el procedimiento mínimamente invasivo, lo que constituye una oportunidad para el mercado del dispositivo de asistencia ventricular izquierda (LVAD). El aumento de la memoria del producto plantea un grave riesgo de seguridad para el público restringe a los fabricantes de productos para obtener beneficios potenciales en el mercado y afecta el tamaño general del mercado, por lo que actúa como desafío para el crecimiento del mercado del dispositivo de asistencia ventricular izquierda (LVAD).

El informe de mercado del dispositivo de asistencia ventricular izquierda (LVAD) proporciona detalles de la cuota de mercado, los nuevos desarrollos y el análisis de tuberías de productos, el impacto de los jugadores de mercado nacionales y localizados, analiza las oportunidades en cuanto a los nuevos bolsillos de ingresos, cambios en las regulaciones de mercado, aprobación de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para entender el análisis y el escenario del mercado de Asistencia Ventricular Izquierda (LVAD) contacte a Data Bridge Market Research para un informe de análisis, nuestro equipo le ayudará a crear una solución de impacto de ingresos para alcanzar su objetivo deseado.

Dispositivo de asistencia ventricular izquierda (LVAD) Alcance del mercado y tamaño del mercado

El mercado de asistencia ventricular izquierda (LVAD) se segmenta en función del tipo de producto, terapia, grupo de edad, indicación, generación, durabilidad, diseño, tipo de pulso, usuario final y canal de distribución. El crecimiento entre segmentos le ayuda a analizar los bolsillos de crecimiento y las estrategias para acercarse al mercado y determinar sus áreas básicas de aplicación y la diferencia en sus mercados de destino.

Sobre la base del tipo de producto, el mercado de asistencia ventricular izquierda (LVAD) se segmenta en bomba de corazón, controlador, baterías y alambres. En 2022, se espera que el segmento de la bomba cardíaca domine el mercado ya que es uno de los componentes principales del dispositivo de asistencia ventricular izquierda y se espera que los avances tecnológicos continuos aceleren el crecimiento del mercado.
Sobre la base de la terapia, el mercado de asistencia ventricular izquierda (LVAD) se segmenta en la terapia puente-transplanta (BTT), la terapia de destino, la terapia puente-a-candidatura (BTC), la terapia puente-a-recuperación (BTR). En 2022, se espera que el segmento de terapia de puente a trasplante dominará el mercado, ya que proporciona apoyo circulatorio a los pacientes elegibles para trasplante hasta que se disponga de un corazón donante.
Sobre la base del grupo de edad, el mercado de asistencia ventricular izquierda (LVAD) se segmenta en adultos y pediátricos. En 2022, se espera que el segmento de adultos domine el mercado, ya que la insuficiencia cardíaca afecta principalmente a la población de adultos de entre 55 años y 75 años.
Sobre la base de la indicación, el mercado de asistencia ventricular izquierda (LVAD) se segmenta en insuficiencia cardíaca congestiva, cardiopatía congénita, miocarditis, paro cardíaco, arritmias familiares y arritmica, cardiomiopatías, insuficiencia cardíaca avanzada y otros. En 2022, se espera que el segmento de insuficiencia cardíaca congestiva domine el mercado, ya que es la insuficiencia cardíaca más común en todo el mundo y conduce a la insuficiencia cardíaca completa también, por lo tanto, las personas afectadas proporcionadas con LVAD para prevenir la creciente incidencia de mortalidad.
Sobre la base de la generación, el mercado de asistencia ventricular izquierda (LVAD) se segmenta en dispositivos de segunda generación, dispositivos de tercera generación y dispositivos de primera generación. En 2022, se espera que los dispositivos de segunda generación dominen el mercado ya que estos dispositivos más pequeños con fácil implantación con bajas tasas de infecciones de transmisión en comparación con los dispositivos de primera generación.
Sobre la base de la durabilidad, el mercado de asistencia ventricular izquierda (LVAD) se segmenta a largo plazo, intermedio y a corto plazo. En 2022, se espera que el segmento a largo plazo domine el mercado, ya que estos dispositivos han mejorado el cuidado de los pacientes que esperan trasplante cardíaco y actúa como terapia alternativa para prevenir pacientes que sufren de insuficiencia cardíaca.
Sobre la base del diseño, el mercado de asistencia ventricular izquierda (LVAD) se segmenta en axial y centrífugo. En 2022, se espera que el segmento axial domine el mercado ya que estos han sido aprobados por primera vez en el mercado y todavía utilizados por varios fabricantes al diseñar LVAD. Además, mejora el estado de vida y mejora la calidad de vida especialmente en pacientes que sobreviven el período perioperatorio. Por el contrario, las bombas centrífugas crecen más rápido en el mercado debido a
Sobre la base del tipo de pulso, el mercado de asistencia ventricular izquierda (LVAD) se segmenta en no pulsatil y púlstil. En 2022, se espera que el segmento no pulsatil domine el mercado, ya que son bombas LVAD de flujo continuo y confiere beneficios funcionales cardíacos a pacientes que sufren de insuficiencia cardíaca de fase final para obtener una mejor capacidad de ejercicio y son ampliamente utilizados para la terapia de destino y la terapia de puente a trasplante.
Sobre la base del usuario final, el mercado de asistencia ventricular izquierda (LVAD) se segmenta en hospitales, clínicas especializadas, laboratorios de catequesis cardiaca y otros. En 2022, se espera que el segmento hospitalario domine el mercado debido a la creciente cantidad de pacientes cardiovasculares debido a la evolución de estilos de vida y la creciente población de ancianos. Además, la presencia de profesionales sanitarios capacitados también está acelerando el crecimiento del mercado.
Sobre la base del canal de distribución, el mercado global de asistencia ventricular izquierda (LVAD) se segmenta en licitación directa, ventas al por menor y otros. En 2022, se espera que el segmento de licitación directa domine el mercado ya que la licitación directa proporciona una mejor calidad de los dispositivos ventriculares izquierdos a un costo reducido en menos tiempo, lo que aumenta la demanda de estos productos.

Dispositivo de asistencia ventricular izquierda (LVAD) Análisis de nivel de mercado

El mercado de asistencia ventricular izquierda (LVAD) es analizado y la información de tamaño del mercado es proporcionada por el país, tipo de producto, terapia, grupo de edad, indicación, generación, durabilidad, diseño, tipo de pulso, usuario final y canal de distribución como se menciona anteriormente.

Los países cubiertos en el informe del mercado del dispositivo de asistencia ventricular izquierda (LVAD) son los Estados Unidos, Canadá, México, Reino Unido, Alemania, Francia, España, Italia, Países Bajos, Suiza, Rusia, Bélgica, Turquía, Irlanda, Resto de Europa, China, Corea del Sur, Japón, India, Australia, Singapur, Malasia, Indonesia, Tailandia, Resto de Asia-Pacífico, Sudáfrica, Arabia Saudita, EE.UU.

Se espera que el segmento de la bomba cardíaca en la región de América del Norte crezca con la mayor tasa de crecimiento en el período de previsión de 2022 a 2029 debido a la creciente prevalencia de enfermedades cardíacas y el aumento del gasto sanitario. Se espera que el segmento de la bomba cardíaca en Alemania domine el mercado europeo debido al creciente número de implantes de LVAD y al aumento de la tasa de implantación de LVAD de puente a trasplante también está aprovechando el crecimiento del mercado. Japón está liderando el crecimiento del segmento de mercado de Asia y el Pacífico y de la bomba cardíaca está dominando en este país debido a la creciente adopción de dispositivos de asistencia ventricular izquierda y el aumento de los avances tecnológicos.

La sección del informe del país también proporciona factores de impacto y cambios de regulación en el mercado nacional que afectan las tendencias actuales y futuras del mercado. Los puntos de datos como las nuevas ventas, las ventas de reemplazo, la demografía de los países, los actos reglamentarios y los aranceles de importación y exportación son algunos de los principales puntos utilizados para prever el escenario del mercado para cada país. Además, la presencia y disponibilidad de marcas mundiales y sus retos a los que se enfrentan debido a la competencia amplia o escasa de las marcas locales y nacionales, se consideran los efectos de los canales de ventas al tiempo que se proporciona un análisis de los datos de los países.

Políticas de reembolso favorables Mejora de la demanda de tratamiento LVAD para enfermedades cardiovasculares y lanzamientos de productos crecientes, está aumentando el crecimiento del mercado del dispositivo de ayuda ventricular izquierda (LVAD)

El mercado del dispositivo de asistencia ventricular izquierda (LVAD) también le proporciona un análisis detallado del mercado para cada crecimiento del país en el mercado particular. Además, proporciona información detallada sobre la estrategia de los jugadores del mercado y su presencia geográfica. Los datos están disponibles para el período histórico 2011-2020.

Paisaje competitivo y dispositivo de asistencia ventricular izquierda (LVAD) Análisis de la participación del mercado

Paisaje competitivo del mercado de ayuda ventricular izquierda (LVAD) proporciona detalles por competidor. Los detalles incluyen información general de la empresa, finanzas de la empresa, ingresos generados, potencial de mercado, inversión en investigación y desarrollo, nuevas iniciativas de mercado, sitios de producción e instalaciones, fortalezas y debilidades de la empresa, lanzamiento de productos, tuberías de ensayos de productos, aprobaciones de productos, anchura de productos y amplitud, dominio de aplicaciones, curva de vida tecnológica. Los puntos de datos arriba proporcionados sólo están relacionados con el enfoque de la empresa relacionado con el mercado del dispositivo de asistencia ventricular izquierda (LVAD).

Las principales empresas que se ocupan del dispositivo de asistencia ventricular izquierda (LVAD) son Abbott, Evaheart, Inc, Saft (A Subsidiary of TotalEnergies), ABIOMED, Berlin Heart, CorWave SA, Jarvik Heart, Inc.among otros jugadores domésticos. Los analistas de DBMR entienden los puntos fuertes competitivos y proporcionan análisis competitivos para cada competidor por separado.

Muchos contratos y acuerdos y crecientes aprobaciones de productos iniciadas por las empresas en todo el mundo que también están acelerando el mercado del dispositivo de asistencia ventricular izquierda (LVAD).

Por ejemplo,

En marzo de 2021, Berlin Heart logró la aprobación del CE y el primer implante de una innovadora solución de cobertura para pacientes monoventrices. Esta innovadora terapia de brida se desarrolló para mejorar la función del organismo final y la hemodinámica de estos pacientes con fisiología univentricular mediante el apoyo de la circulación subpulmonar. Esto ha mejorado la credibilidad de la empresa en el mercado de dispositivos de asistencia ventricular izquierda.
En enero de 2020, Abbott LVAD logró la aprobación de la FDA para implantar sin cirugía abierta. Esta aprobación permitió a los pacientes recibir implante LVAD a través de la toracotomía lateral. Este avance significativo permitió a los pacientes recibir LVAD que salva vidas, lo que ha mejorado la tasa global de recuperación entre los pacientes.

La colaboración, el lanzamiento de productos, la expansión empresarial, la adjudicación y el reconocimiento, las empresas mixtas y otras estrategias del jugador de mercado están mejorando las huellas de la empresa en el mercado del dispositivo de asistencia ventricular izquierda (LVAD) que también proporciona el beneficio para el crecimiento de las ganancias de la organización.

SKU-53362

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Click on image to enlarge

Panel de análisis de datos interactivo
Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
Acceso de analista de investigación para personalización y consultas
Análisis de la competencia con panel interactivo
Últimas noticias, actualizaciones y análisis de tendencias
Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia

Solicitud de demostración

Tabla de contenido

1 INTRODUCCIÓN

1.1 OBJETIVOS DEL ESTUDIO

1.2 DEFINICIÓN DEL MERCADO

1.3 Examen general del mercado de asistencia social (LVAD)

1.4 LIMITACIONES

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 ÁMBIÉN GEOGRÁFICO

2.3 AÑOS ESTUDIOS PARA EL ESTUDIO

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 ENTREVISTAS PRIMARÍAS CON LEADRES DE OPINION KEY

2.9 GRID DE POSICIÓN DEL MERCADO

2.1 MARKET END USUER COVERAGE GRID

2.11 VENDOR SHARE ANALISIS

2.12 CUESTIONES SEGUNDARIAS

2.13

RESUMEN EJECUTIVO

4 fotos INSIGHTS

4.1 PESTEL

4.2 PORTERS

4.3 INSIGHTS INDUSTRIALES:

5 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: REGULATIONS

5.1 REGULACIÓN EN EE.UU.

5.1.1.

5.2 REGULACIÓN EN EUROPA

5.2.1 DIRECTRICES PARA LA MANUTURA:

5.3 REGULACIÓN EN CANADA

5.3.1 DIRECTRICES PARA LA MANUTURA:

5.4 REGULACIÓN EN MÉXICO

5.4.1 DIRECTRICES PARA LA MANUTURA:

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING GERIATRIC POPULATION ALONG with RISING PREVALENCE OF CARDIAC DISEASES

6.1.2 PRESENCIA DE POLÍTICAS DE REIMBUCIÓN FAVORABLES

6.1.3 Modificación de los TRIGIOS LIFESTYLES EL DESARROLLO DE LAS DISEADES CARDIOVASCULAR

6.2 RESTRAINTS

6.2.1 HIGH COST OF LVAD IMPLANTATION AND TREATMENT

6.2.2 COMPLICATIONS AND RISKS ASSOCIATED with LVAD

6.3 OPORTUNIDADES

6.3.1 INCREASE EN LOS GASTOS DE SALUD

6.3.2 INCREASE IN MINIMALLY INVASIVE PROCEDURE

6.3.3 INCREASING SHORTAGE OF ORGAN DONORS

6.3.4 VENTENCIAS TECNOLOGICAS EN PROYECTOS DE ASISTENCIA VENTRICULAR

6.4

6.4.1 ONGOING COVID-19

6.4.2 INCREASE EN RECALLO DEL PRODUCTO

7 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE

7.1 Examen general

7.2 HEART PUMP

7.3

7.4

7.4.1 RECHARGEABLE

7.4.2 NON-RECHARGEABLE

7.5 WIRES

8 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY

8.1 Examen general

8.2 BRIDGE-TO-TRANSPLANT (BTT) THERAPY

8.2.1

8.2.2

8.2.3

8.2.4 WIRES

8.3 THERAPY DESTINATION

8.3.1

8.3.2

8.3.3.

8.3.4 WIRES

8.4 BRIDGE-TO-CANDIDACY (BTC) THERAPY

8.4.1

8.4.2

8.4.3

8.4.4 WIRES

8,5 BRIDGE-TO-RECOVERY (BTR) THERAPY

8.5.1

8.5.2

8.5.3

8.5.4 WIRES

9 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP

9.1 Examen general

9.2 ADULT

9.2.1-39 AÑOS

9.2-59 años

9.2.3-79 AÑOS

9.2.4 ABOVE 80 años

9.3 PEDIATRIC

10 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION

10.1 Examen general

10.2 SEGUNDAS DISPOSICIONES GENERACIÓN

10.3 TERCERA DISPOSICIONES GENERACIÓN

10.4 PRIMER DISPOSICIONES GENERACIÓN

11 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN

11.1 Examen general

11.2 AXIAL

11.3 CENTRIFUGAL

12 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION

12.1 Examen general

12.2 FAILURE DE CORAZÓN CONGESIVA

12.2.1

12.2.2 CONTROLER

12.2.3

12.2.4 WIRES

12.3 DIFERENCIA DE CORAZÓN CONGENITAL

12.3.1

12.3.2

12.3.3.

12.3.4 WIRES

12.4 MYOCARDITIS

12.4.1

12.4.2

12.4.3 BATTERIES

12.4.4 WIRES

12.5 CARDIAC ARREST

12.5.1

12.5.2

12.5.3

12.5.4 WIRES

12.6 FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES

12.6.1

12.6.2

12.6.3 BATTERIES

12.6.4 WIRES

12.7 FAILURE DE CORAZÓN

12.7.1

12.7.2

12.7.3

12.7.4 WIRES

12.8 OTROS

13 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DURABILITY

13.1 Examen general

13.2 LONG-TERM

13.3 INTERMEDIATE-TERM

13.4 SHORT-TERM

14 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY PULSE TYPE

14.1 Examen general

14.2 NONPULSATILE

14.3 PULSATILE

15 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY END USUER

15.1 Examen general

15.2 HOSPITAL

15.3 CARDIAC CATH LABORATORIES

15.4 CLINICS ESPECIALES

15.5 OTROS

16 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DISTRIBUTION CHANNEL

16.1 Examen general

16.2 TENDER DIRECTO

16.3 SALES RETAILES

16.4 OTROS

17 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION

17.1 Examen general

17.2 NORTH AMERICA

17.2.1 Estados Unidos

17.2.2 CANADA

17.2.3 MEXICO

17,3 EUROPA

17.3.1 ALEMANIA

17.3.2 FRANCIA

17.3.3 U.K.

17.3.4 ITALIA

17.3.5 RUSSIA

17.3.6 ESPAÑA

17.3.7 TURKEY

17.3.8 NETHERLANDS

17.3.9 SUIZA

17.3.10 BELGIUM

17.3.11 Irlanda

17.3.12 REST OF EUROPE

17.4 ASIA-PACIFIC

17.4.1 JAPÓN

17.4.2 CHINA

17.4.3 SOUTH KOREA

17.4.4 INDIA

17.4.5 AUSTRALIA

17.4.6

17.4.7 THAILAND

17.4.8 MALAYSIA

17.4.9 PHILIPPINES

17.4.10 INDONESIA

17.4.11 REST OF ASIA-PACIFIC

17,5 MIDDLE EAST " AFRICA

17.5.1 ARABIA SAUDITA

17.5.2 ÁFRICA SUR

17.5.3 Emiratos Árabes Unidos

17.5.4 EGIPTO

17.5.5 ISRAEL

17.5.6 REST OF MIDDLE EAST ' AFRICA

17.6 SOUTH AMERICA

17.6.1 BRASIL

17.6.2 ARGENTINA

17.6.3 REST OF SOUTH AMERICA

18 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALISIS: GLOBAL

18.2 COMPANY SHARE ANALISIS: NORTH AMERICA

18.3 COMPANY SHARE ANALISIS: EUROPA

18.4 COMPANY SHARE ANALISIS: ASIA-PACIFIC

19 ANALISIS DE SWOT

20 COMPANY PROFILE

20.1 ABIOMED

20.1.1 SNAPSHOT

20.1.2 ANÁLISIS REVENIDO

20.1.3 COMPANY SHARE ANALISIS

20.1.4 PRODUCTO PORTFOLIO

20.1.5 ACONTECIMIENTOS RECIENTES

20.1.5.1 FDA APPROVAL

20.1.5.2 FDA APPROVAL

20.2 ABBOTT

20.2.1 SNAPSHOT

20.2.2 ANÁLISIS REVENIDO

20.2.3 COMPANY SHARE ANALISIS

20.2.4 PRODUCTO PORTFOLIO

20.2.5 ACONTECIMIENTOS RECIENTES

20.2.5.1 INCREMENTO SUPPLY

20.2.5.2 BREAK THROUGH DEVICE DESIGNATION

20.3 CORAZÓN DE BERLIN

20.3.1 SNAPSHOT

20.3.2 COMPANY SHARE ANALISIS

20.3.3 PRODUCTO PORTFOLIO

20.3.4 DESARROLLO RECIENTE

20.3.4.1

20.4 SAFT (A SUBSIDIARY OF TOTALENERGIES)

20.4.1 SNAPSHOT

20.4.2 ANÁLISIS REVENIDO

20.4.3 COMPANY SHARE ANALISIS

20.4.4 PRODUCTO PORTFOLIO

20.4.5 DESARROLLO RECIENTE

20.4.5.1

20.5 JARVIK HEART, INC.

20.5.1 SNAPSHOT

20.5.2 ANÁLISIS DE COMPANÍA COMPARTIR

20.5.3 PRODUCTO PORTFOLIO

20.5.4 DESARROLLO RECIENTE

20.5.4.1 FDA APPROVAL

20.6 CORWAVE SA

20.6.1 SNAPSHOT

20.6.2 PRODUCTOS PORTFOLIO

20.6.3 DESARROLLO RECIENTE

20.6.3.1

20.7 EVAHEART, INC

20.7.1 SNAPSHOT

20.7.2 PRODUCTO PORTFOLIO

20.7.3 DESARROLLO RECIENTE

20.7.3.1 PRODUCTO TRIAL

21 CUESTIÓN

22 INFORMES CONEXOS

Lista de Tablas

CUADRO 1 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 GLOBAL HEART PUMP IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 GLOBAL CONTROLLER EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 4 BATTERIES GLOBAL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 5 BATTERIES GLOBAL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 6 GLOBAL WIRES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 7 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 8 GLOBAL BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 9 GLOBAL BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 10 GLOBAL DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 GLOBAL DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 12 GLOBAL BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 13 GLOBAL BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 14 GLOBAL BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 15 GLOBAL BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 16 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 17 GLOBAL ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 18 GLOBAL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 19 GLOBAL PEDIATRIC EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 21 DEVICIOS DE GENERACIÓN SEGUNDA GLOBAL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR REGION, 2020-2029 (USD MILLION)

CUADRO 22 DEVICIOS DE GENERACIÓN GLOBAL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR REGION, 2020-2029 (USD MILLION)

CUADRO 23 DEVICIOS DE GENERACIÓN PRIMERA GLOBAL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR REGION, 2020-2029 (USD MILLION)

CUADRO 24 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 25 GLOBAL AXIAL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 26 GLOBAL CENTRIFUGAL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 27 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 28 GLOBAL CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 29 GLOBAL CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 30 GLOBAL CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR REGION, 2020-2029 (USD MILLION)

CUADRO 31 DEGLOBAL CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 32 GLOBAL MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 33 GLOBAL MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 34 GLOBAL CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 GLOBAL CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 36 GLOBAL FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 37 GLOBAL FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 38 GLOBAL AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR REGION, 2020-2029 (USD MILLION)

CUADRO 39 GLOBAL AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 40 GLOBAL OTHERS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR REGION, 2020-2029 (USD MILLION)

CUADRO 41 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 42 GLOBAL LONG TERM EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 43 GLOBAL INTERMEDIATE-TERM EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 44 GLOBAL SHORT-TERM EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 45 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 46 GLOBAL NONPULSATILE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 47 GLOBAL PULSATILE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 48 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 49 HOSPITALS GLOBAL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 50 LABORATORES DE CARDIAC GLOBAL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR REGION, 2020-2029 (USD MILLION)

CUADRO 51 GLOBAL SPECIALTY CLINICS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 52 OTROS GLOBALES EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR REGION, 2020-2029 (USD MILLION)

CUADRO 53 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 54 GLOBAL DIRECT TENDER IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 55 SALES DE RETAIL GLOBAL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 56 GLOBAL OTHERS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 57 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

CUADRO 58 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PAÍS, 2020-2029 (USD MILLION)

CUADRO 59 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 60 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 61 NORTH AMERICA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 62 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 63 NORTH AMERICA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 64 THERAPY NORTH AMERICA DESTINATION EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 65 NORTH AMERICA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 66 NORTH AMERICA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 67 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 68 NORTH AMERICA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 69 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 70 NORTH AMERICA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 71 AMERICA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 72 NORTH AMERICA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 73 NORTH AMERICA CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 74 NORTH AMERICA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 75 NORTH AMERICA AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 76 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 77 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 78 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 79 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 80 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 81 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 82 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 83 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 84 US BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 85 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 86 U.S. BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 87 US DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 88 U.S. BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 89 US BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 90 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 91 U.S. ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 92 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 93 FAILURO DE CORAZÓN CONGESTIVO DE EE.UU. EN LEFT DEVICE DE ASISTA VENTRICULAR (LVAD), POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 94 CORAZÓN CONGENITAL DEL CORAZÓN DE LOS EE.UU. EN LEFT VENTRICULAR DEVICE ASISTA (LVAD) MARKET, POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 95 U.S. MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 96 U.S. CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 97 U.S. FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 98 U.S. ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 99 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 100 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 101 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 102 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 103 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 104 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 105 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 106 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 107 BATTERIES CANADA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 108 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 109 CANADA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 110 CANADA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 111 CANADA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 112 CANADA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 113 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 114 CANADA ADULT EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 115 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 116 FAILURE CONGESTIVO DEL CORAZÓN CANADA EN LEFT DEVICE VENTRICULAR ASSIST (LVAD) MARKET, POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 117 CANADA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 118 CANADA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 119 CANADA CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 120 FAMILIAL ARRHYTHMIAS CANADA Y CARDIOMÍAS ARRHYTHMIC EN LEFT VENTRICULAR ASSIST DEVICE (LVAD), POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 121 AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 122 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 123 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 124 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 125 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 126 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 127 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 128 MÉXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 129 MÉXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 130 MÉXICOS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 131 MÉXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 132 MÉXICO BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 133 MEXICO DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 134 MÉXICO BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 135 MÉXICO BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 136 MÉXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 137 MÉXICO ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 138 MÉXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 139 MÉXICO CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 140 MÉXICO DISEÑO CONGENITAL DEL CORAZÓN DE ASISTENCIA VENTRICULAR (LVAD) MARKET, POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 141 MÉXICO MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 142 MÉXICO CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 143 MÉXICO FAMILIAL ARRHYTHMIAS Y ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 144 MÉXICO AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 145 MÉXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 146 MÉXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 147 MÉXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 148 MÉXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 149 MÉXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 150 MÉXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 151 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

CUADRO 152 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 153 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 154 EUROPA CARTAS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 155 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 156 EUROPA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 157 EUROPA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 158 EUROPA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 159 EUROPA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 160 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 161 EUROPA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 162 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 163 EUROPA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 164 EUROPA DISEÑO CONGENITAL DE LA CORAZÓN DE LA ASISTENCIA VENTRICULAR (LVAD) MARKET, POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 165 EUROPA MIOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 166 EUROPA CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 167 EUROPA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 168 EUROPA AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 169 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 170 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 171 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 172 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 173 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 174 EUROPA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 175 GERMANY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 176 GERMANY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 177 CARTAS DE ALEMANIA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 178 GERMANY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 179 GERMANY BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 180 GERMANY DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 181 GERMANY BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 182 GERMANY BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 183 GERMANY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 184 GERMANY ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 185 GERMANY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 186 GERMANY CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 187 GERMANY CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 188 GERMANY MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 189 GERMANY CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 190 ALEMANIA FAMILIAL ARRHYTHMIAS Y ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 191 ALEMANIA AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 192 GERMANY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 193 GERMANY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 194 GERMANY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 195 GERMANY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 196 GERMANY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 197 GERMANY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 198 FRANCE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 199 FRANCE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 200 FRANCIAS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 201 FRANCE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 202 FRANCE BRIDGE-to-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 203 FRANCE DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 204 FRANCE BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 205 FRANCE BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 206 FRANCE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 207 FRANCE ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 208 FRANCE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 209 FRANCE CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 210 FRANCE CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 211 FRANCE MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 212 FRANCE CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 213 FRANCE FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 214 FRANCE AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 215 FRANCE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 216 FRANCE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 217 FRANCE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 218 FRANCE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 219 FRANCE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 220 FRANCE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 221 U.K. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 222 U.K. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 223 U.K. BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 224 U.K. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 225 U.K. BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 226 U.K. DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 227 U.K. BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 228 U.K. BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 229 U.K. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 230 U.K. ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 231 U.K. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 232 U.K. CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 233 U.K. CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 234 U.K. MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 235 U.K. CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 236 U.K. FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 237 U.K. AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 238 U.K. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 239 U.K. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 240 U.K. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 241 U.K. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 242 U.K. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 243 U.K. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 244 ITALY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 245 ITALY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 246 TEMAS ITALIAS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 247 ITALY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 248 ITALY BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 249 ITALY DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 250 ITALY BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 251 ITALIA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 252 ITALY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 253 ITALIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 254 ITALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 255 TELEO DE CORAZÓN CONGESIVA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD), POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 256 DATOS CONGENIALES DE LA CORAZÓN DE LA ASISTENCIA VENTRICULAR (LVAD) MARKET, POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 257 ITALIA MIOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 258 ITALY CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 259 ITALIA FAMILIAL ARRHYTHMIAS Y ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 260 FAILURO DE CORAZÓN AVENIDA EN LEFT DEVICE DE ASISTA VENTRICULAR (LVAD) MARKET, POR INDICACIÓN, 2020-2029 (USD MILLION)

TABLE 261 ITALY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 262 ITALY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 263 ITALY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 264 ITALY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 265 ITALY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 266 ITALY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 267 RUSSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 268 RUSSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 269 BATTERIOS RUSSIA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 270 RUSSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 271 RUSSIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 272 RUSSIA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 273 RUSSIA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 274 RUSSIA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 275 RUSSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 276 RUSSIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 277 RUSSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 278 RUSSIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 279 RUSSIA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 280 RUSSIA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 281 RUSSIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 282 RUSSIA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 283 RUSSIA AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 284 RUSSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 285 RUSSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 286 RUSSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 287 RUSSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 288 RUSSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 289 RUSSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 290 ESPAÑA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 291 ESPAÑA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 292 ESPAÑA DE LA MERCADO DE VENTRICULAR ASSIST DEVICE (LVAD), POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 293 ESPAÑA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 294 SPAIN BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 295 SPAIN DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 296 ESPAÑA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 297 ESPAÑA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 298 ESPAÑA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 299 ESPAÑA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 300 ESPAÑA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 301 ESPAÑA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 302 ESPAÑA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 303 ESPAÑA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 304 ESPAÑA CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 305 ESPAÑA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 306 ESPAÑA AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 307 ESPAÑA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 308 ESPAÑA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 309 ESPAÑA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 310 ESPAÑA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 311 ESPAÑA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 312 ESPAÑA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 313 TURKEY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 314 TURKEY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 315 TURQUÍAS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 316 TURKEY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 317 BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 318 TURKEY DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 319 TURKEY BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 320 TURKEY BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 321 TURKEY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 322 TURKEY ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 323 TURKEY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 324 TURQUÍA DE CORAZÓN CONGESTIVO FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 325 TURQUÍA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 326 TURKEY MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 327 TURQUÍA CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 328 FAMILIAL ARRHYTHMIAS Y ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 329 AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 330 TURKEY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 331 TURKEY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 332 TURKEY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 333 TURKEY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 334 TURKEY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 335 TURKEY LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 336 NETHERLANDS LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 337 NETHERLANDS LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 338 NETHERLANDS BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 339 NETHERLANDS LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 340 NETHERLANDS BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 341 NETHERLANDS DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 342 NETHERLANDS BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 343 NETHERLANDS BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 344 NETHERLANDS LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 345 NETHERLANDS ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 346 NETHERLANDS LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 347 NETHERLANDS CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 348 NETHERLANDS CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 349 NETHERLANDS MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 350 NETHERLANDS CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 351 NETHERLANDS FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 352 NETHERLANDS ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 353 NETHERLANDS LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 354 NETHERLANDS LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 355 NETHERLANDS LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 356 NETHERLANDS LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 357 NETHERLANDS LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 358 NETHERLANDS LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 359 SWITZERLAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 360 SWITZERLAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 361 BATTERIOS DE SUIZA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 362 SWITZERLAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 363 SWITZERLAND BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 364 SWITZERLAND DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 365 SWITZERLAND BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 366 SWITZERLAND BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 367 SWITZERLAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 368 SWITZERLAND ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 369 SWITZERLAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 370 DE SWITZERLAND CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 371 SUIZA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 372 SWITZERLAND MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 373 SUIZA CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 374 SUIZA FAMILIAL ARRHYTHMIAS Y ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 375 SUIZA FAILURE AVANCED HEART EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 376 SWITZERLAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 377 SWITZERLAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 378 SWITZERLAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 379 SWITZERLAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 380 SWITZERLAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 381 SWITZERLAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 382 BELGIUM LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 383 BELGIUM LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 384 BATTERIES BELGIUM EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 385 BELGIUM LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 386 BELGIUM BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 387 BELGIUM DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 388 BELGIUM BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 389 BELGIUM BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 390 BELGIUM LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 391 BELGIUM ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 392 BELGIUM LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 393 CARACTERIO CONGESTIVO DE CORAZÓN DE CORAZÓN LEFT VENTRICULAR DEVICE DE ASISTA (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 394 TELEGIUM CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 395 BELGIUM MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 396 CARDIAC BELGIUM ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 397 BELGIUM FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 398 BELGIUM AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 399 BELGIUM LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 400 BELGIUM LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 401 BELGIUM LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 402 BELGIUM LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 403 BELGIUM LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 404 BELGIUM LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 405 IRELAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 406 IRELAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 407 CARTAS DE IRLANDA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 408 IRELAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 409 IRELAND BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 410 THERAPY DE DESTINACIÓN IRLANDA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 411 IRELAND BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 412 IRELAND BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 413 IRELAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 414 IRLANDA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 415 IRELAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 416 CARTA DE CORAZÓN CONGESIVA DE IRLANDA FAILURE EN LEFT VENTRICULAR ASIST DEVICE (LVAD), POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 417 DESARME CONGENIAL DE IRLANDA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 418 IRELAND MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 419 CARDIAC DE IRLANDA ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 420 IRLANDA FAMILIAL ARRHYTHMIAS Y ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 421 AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 422 IRELAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 423 IRELAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 424 IRELAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 425 IRELAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 426 IRELAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 427 IRELAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 428 REST OF EUROPE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 429 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PAÍS, 2022-2029 (USD MILLION)

CUADRO 430 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 431 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 432 ASIA-PACIFIC BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 433 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 434 ASIA-PACIFIC BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 435 ASIA-PACIFIC DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 436 ASIA-PACIFIC BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 437 ASIA-PACIFIC BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 438 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 439 ASIA-PACIFIC ADULT EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 440 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 441 ASIA-PACIFIC CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 442 DATOS CONGENIALES ASIA-PACIFICOS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 443 ASIA-PACIFIC MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 444 CARDIAC ASIA-PACIFIC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 445 ASIA-PACIFIC FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 446 ASIA-PACIFIC AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 447 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 448 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 449 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 450 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 451 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 452 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 453 JAPÓN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 454 JAPÓN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 455 BATTERIES JAPAN EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 456 JAPÓN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 457 JAPÓN BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 458 JAPAN DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 459 JAPÓN BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 460 JAPÓN BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 461 JAPÓN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 462 JAPÓN EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 463 JAPÓN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 464 JAPÓN FAILURE CONGESTIVO DEL CORAZÓN LEFT VENTRICULAR ASIST DEVICE (LVAD) MARKET, POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 465 JAPÓN CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 466 JAPÓN MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 467 JAPÓN CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 468 ARRHYTHMIAS JAPÓN Y CARDIOMÍAS ARRHYTHMIC EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 469 JAPÓN AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 470 JAPÓN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 471 JAPÓN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 472 JAPÓN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 473 JAPÓN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 474 JAPÓN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 475 JAPÓN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 476 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 477 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 478 CARTAS DE CHINA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 479 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 480 CHINA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 481 THERAPY DESTINATION EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 482 CHINA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 483 CHINA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 484 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 485 CHINA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 486 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 487 CHINA CONGESTIVE HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 488 CHINA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 489 CHINA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 490 CHINA CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 491 CHINA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 492 CHINA AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 493 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 494 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 495 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 496 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 497 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 498 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 499 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 500 KOREA SOUTH LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 501 CARTAS DE COREA SUR EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 502 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 503 SOUTH KOREA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 504 SOUTH KOREA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 505 SOUTH KOREA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 506 SOUTH KOREA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 507 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 508 SOUTH KOREA ADULT EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 509 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 510 SOUTH KOREA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 511 SOUTH COREA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 512 SOUTH KOREA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 513 SOUTH KOREA CARDIAC ARREST EN LEFT VENTRICULAR ASIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 514 DE COREA FAMILIAL ARRHYTHMIAS Y ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 515 SOUTH KOREA AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 516 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 517 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 518 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 519 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 520 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 521 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 522 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 523 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 524 CARTAS INDIA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 525 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 526 INDIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 527 INDIA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 528 INDIA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 529 INDIA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 530 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 531 INDIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 532 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 533 INDIA CONGESTIVE HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 534 INDIA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 535 INDIA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 536 INDIA CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 537 INDIA FAMILIAL ARRHYTHMIAS Y ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 538 INDIA AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 539 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 540 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 541 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 542 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 543 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 544 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 545 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 546 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 547 AUSTRALIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 548 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 549 AUSTRALIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 550 AUSTRALIA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 551 AUSTRALIA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 552 AUSTRALIA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 553 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 554 AUSTRALIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 555 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 556 AUSTRALIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 557 AUSTRALIA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 558 AUSTRALIA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 559 AUSTRALIA CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 560 AUSTRALIA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 561 AUSTRALIA AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 562 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 563 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 564 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 565 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 566 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 567 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 568 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 569 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 570 CARTAS DE SINGAPORE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 571 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 572 SINGAPORE BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 573 SINGAPORE DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 574 SINGAPORE BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 575 SINGAPORE BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 576 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 577 SINGAPORE ADULT EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 578 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 579 SINGAPORE CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 580 SINGAPORE CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 581 SINGAPORE MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 582 SINGAPORE CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 583 SINGAPORE FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 584 FAILURE DE CORAZÓN AVANCED DE LA LEFT VENTRICULAR DEVICE DE ASISTA (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 585 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 586 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 587 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 588 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 589 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 590 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 591 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 592 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 593 TEAILAND BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 594 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 595 THAILAND BRIDGE-to-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 596 THAILAND DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 597 THAILAND BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 598 THAILAND BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 599 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 600 THAILAND ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 601 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 602 THAILAND CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 603 THAILAND CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 604 THAILAND MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 605 THAILAND CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 606 THAILAND FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 607 TEAILANDA AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 608 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 609 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 610 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 611 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 612 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 613 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 614 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 615 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 616 MALAYSIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 617 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 618 MALAYSIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 619 MALAYSIA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 620 MALAYSIA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 621 MALAYSIA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 622 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 623 MALAYSIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 624 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 625 MALAYSIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 626 MALAYSIA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 627 MALAYSIA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 628 MALAYSIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 629 MALAYSIA FAMILIAL ARRHYTHMIAS Y ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 630 MALAYSIA AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 631 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 632 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 633 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 634 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 635 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 636 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 637 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 638 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 639 PHILIPPINES BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 640 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 641 PHILIPPINES BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 642 PHILIPPINES DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 643 PHILIPPINES BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 644 PHILIPPINES BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 645 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 646 PHILIPPINES ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 647 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 648 PHILIPPINES CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 649 PHILIPPINES CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 650 PHILIPPINES MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 651 PHILIPPINES CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 652 PHILIPPINES FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 653 PHILIPPINES AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 654 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 655 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 656 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 657 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 658 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 659 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 660 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 661 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 662 INDONESIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 663 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 664 INDONESIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 665 INDONESIA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 666 INDONESIA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 667 INDONESIA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 668 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 669 INDONESIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 670 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 671 INDONESIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 672 INDONESIA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 673 INDONESIA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 674 INDONESIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 675 INDONESIA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 676 INDONESIA AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 677 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 678 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 679 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 680 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 681 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 682 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 683 REST OF ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 684 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

CUADRO 685 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 686 MIDDLE EAST " AFRICA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 687 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 688 MIDDLE EAST " AFRICA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 689 MIDDLE EAST " AFRICA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 690 MIDDLE EAST " AFRICA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 691 MIDDLE EAST " AFRICA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 692 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 693 MIDDLE EAST " AFRICA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 694 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 695 MIDDLE EAST " AFRICA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 696 MIDDLE EAST " AFRICA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 697 MIDDLE EAST " AFRICA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 698 MIDDLE EAST " AFRICA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 699 MIDDLE EAST " AFRICA FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 700 MIDDLE EAST " AFRICA AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 701 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 702 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 703 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 704 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 705 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 706 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 707 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 708 ARABIAS SAUDIOS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 709 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 710 ARABIA SAUDIO BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 711 SAUDI ARABIA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 712 ARABIA SAUDIO BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)

CUADRO 713 ARABIA SAUDIO BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)

CUADRO 714 ARABIA SAUDIO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 715 ARABIA SAUDIO ADULT EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)

TABLE 716 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 717 SAUDI ARABIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 718 SAUDI ARABIA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 719 ARABIA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 720 SAUDI ARABIA CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 721 SAUDI ARABIA FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 722 ARABIA SAUDIO AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 723 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 724 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 725 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 726 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 727 ARABIA SAUDITA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 728 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 729 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 730 BATTERIES SOUTH AFRICA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 731 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 732 SOUTH AFRICA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 733 SOUTH AFRICA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 734 SOUTH AFRICA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)

CUADRO 735 SOUTH AFRICA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)

TABLE 736 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 737 ADULT SOUTH AFRICA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)

TABLE 738 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 739 SOUTH AFRICA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 740 SOUTH AFRICA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 741 SOUTH AFRICA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 742 CARDIAC SOUTH AFRICA ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 743 FAMILIAL SOUTH AFRICA ARRHYTHYMIAS AND ARRHYTHMIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 744 SOUTH AFRICA AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 745 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 746 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 747 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 748 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 749 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 750 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 751 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 752 U.A.E. BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 753 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 754 U.A.E. BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 755 U.A.E. DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 756 U.A.E. BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)

CUADRO 757 U.A.E. BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)

CUADRO 758 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 759 U.A.E. ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 760 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

TABLE 761 U.A.E. CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 762 U.A.E. CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 763 U.A.E. MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 764 U.A.E. CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 765 U.A.E. FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 766 U.A.E. AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 767 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 768 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 769 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 770 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 771 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 772 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 773 EGIPTO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 774 CARTAS DE EGIPTO EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 775 EGIPTO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 776 EGIPTO BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 777 EGIPTO DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 778 EGIPTO BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)

CUADRO 779 EGIPTO BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)

CUADRO 780 EGIPTO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 781 EGIPTO ADULT EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 782 EGIPTO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 783 EGIPTO CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 784 EGIPTO CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 785 EGIPTO MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 786 EGIPTO CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 787 EGIPTO FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 788 EGIPTO AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 789 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 790 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 791 EGIPTO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 792 EGIPTO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 793 EGIPTO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 794 EGIPTO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 795 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 796 TEMAS ISRAEL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 797 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 798 ISRAEL BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 799 ISRAEL DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 800 ISRAEL BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)

CUADRO 801 ISRAEL BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)

CUADRO 802 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 803 ISRAEL ADULT EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 804 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 805 DE CORAZÓN CONGESTIVO DEL ISRAEL FAILURE EN LEFT VENTRICULAR ASIST DEVICE (LVAD) MARKET, POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 806 DATOS CONGENIALES DE LA CORAZÓN DE LA ASISTENCIA VENTRICULAR (LVAD) MARKET, POR INDICACIÓN, 2020-2029 (USD MILLION)

CUADRO 807 ISRAEL MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 808 ISRAEL CARDIAC ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 809 ISRAEL FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 810 ISRAEL AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 811 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

CUADRO 812 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 813 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 814 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 815 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 816 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 817 REST OF MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 818 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PAÍS, 2020-2029 (USD MILLION)

TABLE 819 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 820 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 821 BATTERIES SOUTH AMERICA EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 822 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 823 SOUTH AMERICA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 824 SOUTH AMERICA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 825 SOUTH AMERICA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 826 SOUTH AMERICA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 827 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 828 SOUTH AMERICA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 829 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 830 SOUTH AMERICA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 831 SOUTH AMERICA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 832 SOUTH AMERICA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 833 CARDIAC SOUTH AMERICA ARREST EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 834 AMERICA FAMILIAL ARRHYTHMIAS Y ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 835 AMERICA SUR AMERICA AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 836 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 837 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 838 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 839 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 840 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 841 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 842 BRAZIL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 843 BRAZIL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

CUADRO 844 BATTERIES BRASIL EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 845 BRAZIL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 846 BRAZIL BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 847 BRAZIL DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 848 BRAZIL BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 849 BRAZIL BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 850 BRAZIL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 851 BRAZIL ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 852 BRAZIL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 853 BRAZIL CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 854 BRAZIL CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR INDICATION, 2020-2029 (USD MILLION)

CUADRO 855 BRAZIL MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 856 BRAZIL CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 857 BRAZIL FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 858 BRAZIL AVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 859 BRASIL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 860 BRAZIL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 861 BRASIL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 862 BRASIL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 863 BRAZIL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 864 BRAZIL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 865 ARGENTINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 866 ARGENTINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 867 ARGENTINA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 868 ARGENTINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 869 ARGENTINA BRIDGE-TO-TRANSPLANT (BTT) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

TABLE 870 ARGENTINA DESTINATION THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

CUADRO 871 ARGENTINA BRIDGE-TO-CANDIDACY (BTC) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 872 ARGENTINA BRIDGE-TO-RECOVERY (BTR) THERAPY EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, POR THERAPY, 2020-2029 (USD MILLION)

CUADRO 873 ARGENTINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 874 ARGENTINA ADULT EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

CUADRO 875 ARGENTINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 876 ARGENTINA CONGESTIVE HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 877 ARGENTINA CONGENITAL HEART DISEASE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 878 ARGENTINA MYOCARDITIS EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 879 ARGENTINA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 880 ARGENTINA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 881 ARGENTINA AVANCED HEART FAILURE EN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

CUADRO 882 ARGENTINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 883 ARGENTINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

CUADRO 884 ARGENTINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

CUADRO 885 ARGENTINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

CUADRO 886 ARGENTINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

CUADRO 887 ARGENTINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

CUADRO 888 REST OF SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CUADRO 889 REST OF SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

Lista de figuras

FIGURE 1 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SEGMENTATION

FIGURE 2 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: GLOBAL VS REGIONAL ANALYSIS

FIGURE 5 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: END USER COVERAGE GRID

FIGURE 9 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET:VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SEGMENTATION

FIGURE 11 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASE AND RISING HEALTHCARE EXPENDITURE are EXPECTED TO DRIVE THE GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET IN THE FORECAST PERIOD of 2022 to 2029

FIGURE 12 HEART PUMP SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET IN 2022 & 2029

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET AND ASIA-PACIFIC TO GROW with the HIGHGHEST CAGR IN THE FORECAST PERIOD of 2022 to 2029

FIGURE 14 ASIA-PACIFIC is the FASTEST-GROWING MARKET FOR LEFT VENTRICULAR ASSIST DEVICE (LVAD) MANUFACTURES IN THE FORECAST PERIOD of 2022 to 2029

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET

FIGURE 16 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, 2021

FIGURE 17 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, 2020-2029 (USD MILLION)

FIGURE 18 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, CAGR (2022-2029)

FIGURE 19 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 20 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, 2021

FIGURE 21 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, 2020-2029 (USD MILLION)

FIGURE 22 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, CAGR (2022-2029)

FIGURE 23 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, LIFELINE CURVE

FIGURE 24 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, 2021

FIGURE 25 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, 2020-2029 (USD MILLION)

FIGURE 26 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, CAGR (2022-2029)

FIGURE 27 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 28 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, 2021

FIGURE 29 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, 2020-2029 (USD MILLION)

FIGURE 30 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, CAGR (2022-2029)

FIGURE 31 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, LIFELINE CURVE

FIGURE 32 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, 2021

FIGURE 33 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, 2020-2029 (USD MILLION)

FIGURE 34 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, CAGR (2022-2029)

FIGURE 35 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, LIFELINE CURVE

FIGURE 36 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, 2021

FIGURE 37 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, 2020-2029 (USD MILLION)

FIGURE 38 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, CAGR (2022-2029)

FIGURE 39 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, LIFELINE CURVE

FIGURE 40 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, 2021

FIGURE 41 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, 2020-2029 (USD MILLION)

FIGURE 42 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, CAGR (2022-2029)

FIGURE 43 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, LIFELINE CURVE

FIGURE 44 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, 2021

FIGURE 45 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, 2020-2029 (USD MILLION)

FIGURE 46 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, CAGR (2022-2029)

FIGURE 47 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, LIFELINE CURVE

FIGURE 48 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, 2021

FIGURE 49 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, 2020-2029 (USD MILLION)

FIGURE 50 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, CAGR (2022-2029)

FIGURE 51 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, LIFELINE CURVE

FIGURE 52 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 53 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

FIGURE 54 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 55 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 56 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SNAPSHOT (2021)

FIGURE 57 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY REGION (2021)

FIGURE 58 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY REGION (2022 & 2029)

FIGURE 59 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY REGION (2021 & 2029)

FIGURE 60 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 61 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SNAPSHOT (2021)

FIGURE 62 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021)

FIGURE 63 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2022 & 2029)

FIGURE 64 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021 & 2029)

FIGURE 65 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 66 EUROPE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SNAPSHOT (2021)

FIGURE 67 EUROPE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021)

FIGURE 68 EUROPE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2022 & 2029)

FIGURE 69 EUROPE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021 & 2029)

FIGURE 70 EUROPE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 71 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SNAPSHOT (2021)

FIGURE 72 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021)

FIGURE 73 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2022 & 2029)

FIGURE 74 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021 & 2029)

FIGURE 75 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 76 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SNAPSHOT (2021)

FIGURE 77 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021)

FIGURE 78 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2022 " 2029)

FIGURE 79 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021 " 2029)

FIGURE 80 MIDDLE EAST " AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 81 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SNAPSHOT (2021)

FIGURE 82 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021)

FIGURE 83 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2022 & 2029)

FIGURE 84 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021 & 2029)

FIGURE 85 SOUTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 86 GLOBAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY SHARE 2021 (%)

FIGURE 87 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY SHARE 2021 (%)

FIGURE 88 EUROPE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY SHARE 2021 (%)

FIGURE 89 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY SHARE 2021 (%)

Ver información detallada

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Mercado mundial de dispositivos de asistencia ventricular izquierda (LVAD): tendencias de la industria y pronóstico hasta 2029